Globus Medical, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
120.00
165.00
243.00
180.00
125.00
189.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-97.00
-116.00
-105.00
-17.00
-37.00
-73.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
520.00
243.00
178.00
276.00
198.00
171.00
Cash Flow from Investing Activities
-176.00
302.00
-110.00
-375.00
-117.00
-140.00
Cash Flow from Financing Activities
-27.00
-231.00
-109.00
54.00
-38.00
24.00
Net Cash Inflow / Outflow
317.00
316.00
-42.00
-46.00
43.00
55.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
2.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Globus Medical, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
120.722
149.993
-29.00
-19.51%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-97.554
-36.945
-61.00
-164.05%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
520.638
220.799
300.00
135.80%
Cash Flow from Investing Activities
-176.051
-368.653
192.00
52.24%
Cash Flow from Financing Activities
-27.696
-60.008
33.00
53.85%
Net Cash Inflow / Outflow
317.146
-210.377
527.00
250.75%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.255
-2.515
2.00
110.14%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 113.82% vs 36.44% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
520.64
243.50
113.82%






